admin – Page 5 – Aberdeen International

July 15, 2021

Aberdeen Acquires Securities in Medivolve

TORONTO, July 15, 2021 (GLOBE NEWSWIRE) — ABERDEEN INTERNATIONAL INC. (“Aberdeen” or the “Company”) (TSX: AAB) has acquired 24,101,803 units of Medivolve Inc. (“Medivolve”) (NEO: MEDV) in a non-brokered private placement financing of MEDV at a price of $0.07 per unit for a total subscription price of $1,687,126.21. Each unit is comprised of one Medivolve common share and one Medivolve common share purchase warrant. Each common share purchase warrant is exercisable for one common share of Medivolve at a price of $0.08 for a period of five years. Prior to this transaction, Aberdeen did not own Common Shares of MEDIVOLVE. Subsequent to […]

July 15, 2021

Aberdeen Announces AGM Results

TORONTO, July 15, 2021 (GLOBE NEWSWIRE) — Aberdeen International Inc. (“Aberdeen” or the “Company”) (TSX: AAB) (FRANKFURT: A8H) (OTC: AABVF) reports, in accordance with the policies of the Toronto Stock Exchange, that the nominees listed in the management proxy circular dated June 14, 2021 for the 2021 annual meeting of shareholders of Aberdeen held on July 15, 2021 (the “Meeting”) were elected as directors of the Company. Aberdeen management would like to thank shareholders for their participation and continuing support. Detailed results of the vote for the election of directors held at the Meeting are set out below. A total of 33,876,003 […]

June 14, 2021

Aberdeen International Inc. (TSX: AAB, FR: A8H, OTC: AABVF) Reports 2021 Q1 Results With Net Income Of $0.02 Per Share And Shareholders’ Equity Of $0.30 Per Share

— Total revenue of $4.0 million, including net gain on investments of $3.9 million — Net income for the three months ended April 30, 2021 was $3.3 million or $0.02 per basic share — As at April 30, 2021, Aberdeen’s shareholders’ equity and net asset value (NAV) were $41.0 million, or $0.30 per share. On a quarter-over-year basis, Aberdeen’s shareholders’ equity has increased by $8.6 million, representing an approximate 26% increase. Given the nature of Aberdeen’s operations, there is currently no difference between “shareholder equity” and “net asset value” for Aberdeen — Investments in clean energy and zero-carbon technologies positioning […]

April 21, 2021

Nuclear energy plants could help accelerate hydrogen adoption with reduced costs

By George Heynes With the breakthrough of hydrogen technology in various decarbonisation strategies across the world, nuclear reactors could be given a new lease of life by providing almost perfect conditions to produce green hydrogen on a massive scale. It is not often you find two products that, ethically, are at opposite ends of the spectrum but complement each other so significantly. The reputational facelift that nuclear power has needed since it was first introduced in the last century could be realised with the introduction of technologies that utilise by-products of nuclear power to generate alternative fuel sources such as hydrogen. […]

April 8, 2021

Nuclear plants could be the ‘perfect component’ for green hydrogen production

By George Heynes Clean energy technology company AES-100 is investigating whether hydrogen production could, under the right conditions, offer a solution for US and European nuclear reactors to retire early and help new reactors run to high efficiencies. Read more: Xcel Energy and Idaho National Laboratory to use nuclear energy for hydrogen production Read more: AES technology selected for Californian green hydrogen energy storage project In the current climate, nuclear power plants find it difficult to compete with cheaper natural gas and renewable energy generation meaning that many are forced to retire early with no short-term way of destroying nuclear reactors. However, the […]